Reuters logo
Quest Diagnostics profit misses estimates
July 18, 2013 / 11:11 AM / 4 years ago

Quest Diagnostics profit misses estimates

July 18 (Reuters) - Laboratory tests provider Quest Diagnostics Inc’s results missed analysts’ expectations for the third straight quarter, hurt by a cut in Medicare reimbursements.

Quest reported a second-quarter adjusted profit of $1.06 cents per share from continuing operations on revenue of $1.82 billion.

Analysts on average had expected a profit of $1.09 per share and revenue of $1.84 billion, according to Thomson Reuters I/B/E/S.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below